Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:02429542n
Noun Concept
Categories: Disease-modifying antirheumatic drugs, Chemicals using indexlabels, Pfizer brands, Non-receptor tyrosine kinase inhibitors, Multiple chemicals in Infobox drug
EN
tofacitinib  ATC code L04AA29  ATCvet code QL04AA29  CP-690,550  CP-690550
EN
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis, and ulcerative colitis. Wikipedia
Definitions
Relations
Sources
EN
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis, and ulcerative colitis. Wikipedia
Chemical compound Wikidata
IS A
compound
medicine
MEDICAL CONDITION TREATED
alopecia areata
arthritis
baldness
ulcerative colitis
polyarthritis
SUBJECT HAS ROLE
protein kinase inhibitor
Wikipedia
EN
tofacitinib
Wikidata
EN
tofacitinib
Wikipedia Redirections
EN
ATC code L04AA29, ATCvet code QL04AA29, CP-690,550, tasocitinib, tofacitinib citrate, Xeljanz, Xeljanz XR
Wikidata Alias
EN
CP-690,550, CP-690550, tasocitinib, Xeljanz®

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License